Two years of high-efficacy therapy reduces disease activity and brain volume loss in Japanese patients with relapse-onset multiple sclerosis
MULTIPLE SCLEROSIS JOURNAL(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
MULTIPLE SCLEROSIS JOURNAL(2022)